Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Q: What does CUSIP 87990A106 represent in this 13F holders report?

CUSIP 87990A106 is the security identifier for TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q3 2021?

44 institutional investors reported TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q3 2021. Use the holders table for investor-level position and value details.

CUSIP: 87990A106

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 213,832,909
Total 13F shares: 24,450,664
Share change: +24,450,664
Total reported value: $499,284,447
Price per share: $20.65
Number of holders: 44
Value change: +$499,284,447
Number of buys: 44

Quarterly Holders Quick Answers

What is CUSIP 87990A106?
CUSIP 87990A106 identifies TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2021

Recent filing periods for CUSIP 87990A106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Casdin Partners Master Fund, L.P.	3/4/5	10%+ Owner	— class O/S missing	361,969	$1,541,988	—	03 Aug 2021	3/4/5
JeenJoo Kang	3/4/5	Director	— class O/S missing	25,000	$106,500	—	03 Aug 2021	3/4/5

Institutional Holders of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) as of Q3 2021

As of 30 Sep 2021, Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,450,664 shares. The largest 10 holders included FMR LLC, Casdin Capital, LLC, RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, BlackRock Inc., Euclidean Capital LLC, Alphabet Inc., HARVARD MANAGEMENT CO INC, and COMMODORE CAPITAL LP. This page lists 44 institutional shareholders reporting positions in this security for the Q3 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2021 vs Q4 2025 Across Filers

Q4 2025 holders

Q3 2021 holders

Holder diff

-51

Investor	Q4 2025 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q3 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.